Central Pharmaceutical Joint Stock Company No3 announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was VND 95,422.056 million compared to VND 93,190.220 million a year ago. Operating income was VND 39,304.351 million compared to VND 42,185.892 million a year ago. Net income was VND 31,048.510 million compared to VND 33,576.758 million a year ago. Basic earnings per share from continuing operations was VND 3,610 compared to VND 3,904 a year ago. For the half year, total revenue was VND 193,095.000 million compared to VND 204,603.000 million a year ago. Operating income was VND 61,299.519 million compared to VND 70,332.172 million a year ago. Net income was VND 48,929.909 million compared to VND 56,376.001 million a year ago. Basic earnings per share from continuing operations was VND 5,690 compared to VND 6,555 a year ago.